Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
Asia-Pacific Journal of Clinical Oncology
|
April 20, 2010
Bone disease in prostate cancer
Adnan Nagrial, Lisa Horvath
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 29, 2014
Cardiac metastasis in Merkel cell carcinoma
Clare F Suttie, George Hruby, Lisa Horvath, et al.
Pathology
|
January 15, 2011
What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements
Wendy A Cooper, Sandra O'toole, Michael Boyer, et al.
Proteomics. Clinical Applications
|
September 25, 2012
Remarkable temporal stability of high-abundance human plasma proteins assessed by targeted mass spectrometry
Sarah A Randall, Matthew J McKay, Dana Pascovici, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 8, 2024
The Cost-Effectiveness of Germline BReast CAncer Gene Testing in Metastatic Prostate Cancer Followed by Cascade Testing of First-Degree Relatives of Mutation Carriers
Srinivas Teppala, Paul Scuffham, Kim Edmunds, et al.
Prostate Cancer and Prostatic Diseases
|
May 18, 2023
Guidelines for genetic testing in prostate cancer: a scoping review
Haitham Tuffaha, Kim Edmunds, David Fairbairn, et al.
Familial Cancer
|
January 24, 2026
Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how?
Kim Edmunds, Shiksha Arora, Sri Teppala, et al.
Investigational New Drugs
|
April 27, 2025
Phase 1 study of HP518, a PROTAC AR degrader in patients with mCRPC: results on safety, pharmacokinetics, and anti-tumor activity
Arun A Azad, Howard Gurney, Craig Underhill, et al.
Clinical Colorectal Cancer
|
January 7, 2011
Cetuximab is associated with excessive toxicity when combined with bevacizumab Plus mFOLFOX6 in metastatic colorectal carcinoma
Allyson J Ocean, Blase Polite, Paul Christos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 14, 2019
Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy
J Matt McCrary, David Goldstein, Carolina X Sandler, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
Asia-Pacific Journal of Clinical Oncology
|
April 20, 2010
Bone disease in prostate cancer
Adnan Nagrial, Lisa Horvath
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 29, 2014
Cardiac metastasis in Merkel cell carcinoma
Clare F Suttie, George Hruby, Lisa Horvath, et al.
Pathology
|
January 15, 2011
What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements
Wendy A Cooper, Sandra O'toole, Michael Boyer, et al.
Proteomics. Clinical Applications
|
September 25, 2012
Remarkable temporal stability of high-abundance human plasma proteins assessed by targeted mass spectrometry
Sarah A Randall, Matthew J McKay, Dana Pascovici, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 8, 2024
The Cost-Effectiveness of Germline BReast CAncer Gene Testing in Metastatic Prostate Cancer Followed by Cascade Testing of First-Degree Relatives of Mutation Carriers
Srinivas Teppala, Paul Scuffham, Kim Edmunds, et al.
Prostate Cancer and Prostatic Diseases
|
May 18, 2023
Guidelines for genetic testing in prostate cancer: a scoping review
Haitham Tuffaha, Kim Edmunds, David Fairbairn, et al.
Familial Cancer
|
January 24, 2026
Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how?
Kim Edmunds, Shiksha Arora, Sri Teppala, et al.
Investigational New Drugs
|
April 27, 2025
Phase 1 study of HP518, a PROTAC AR degrader in patients with mCRPC: results on safety, pharmacokinetics, and anti-tumor activity
Arun A Azad, Howard Gurney, Craig Underhill, et al.
Clinical Colorectal Cancer
|
January 7, 2011
Cetuximab is associated with excessive toxicity when combined with bevacizumab Plus mFOLFOX6 in metastatic colorectal carcinoma
Allyson J Ocean, Blase Polite, Paul Christos, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 14, 2019
Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy
J Matt McCrary, David Goldstein, Carolina X Sandler, et al.
Page
of 5